{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T08:19:52Z","timestamp":1778746792324,"version":"3.51.4"},"reference-count":45,"publisher":"Informa UK Limited","issue":"3","funder":[{"name":"funded by any means"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Biological Therapy"],"published-print":{"date-parts":[[2019,3,4]]},"DOI":"10.1080\/14712598.2019.1566456","type":"journal-article","created":{"date-parts":[[2019,1,8]],"date-time":"2019-01-08T23:12:02Z","timestamp":1546989122000},"page":"173-179","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":26,"title":["Etanercept biosimilar SB-4"],"prefix":"10.1080","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9383-5722","authenticated-orcid":false,"given":"Eleftherios","family":"Pelechas","sequence":"first","affiliation":[{"name":"Rheumatology Clinic, Department of Internal Medicine, Medical School, University of Ioannina, Ioannina, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2232-0326","authenticated-orcid":false,"given":"Alexandros A.","family":"Drosos","sequence":"additional","affiliation":[{"name":"Rheumatology Clinic, Department of Internal Medicine, Medical School, University of Ioannina, Ioannina, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2019,1,11]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2018.06.003"},{"key":"CIT0002","first-page":"212543","volume":"7","author":"Kos IA","year":"2018","journal-title":"Drugs Context"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1517\/14712598.2015.1083552"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1586\/1744666X.2015.1090313"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-209166"},{"key":"CIT0006","unstructured":"GaBI Online \u2013 Generics and Biosimilars Initiative. Biosimilar etanercept offered at 47% discount in Norway [www.gabiolinile.net]. Mol: Pro Pharma Communications International; [cited 2018 Sep 12]. Available from: http:\/\/wwwgabionline.net\/Biosimilars\/General\/Biosimilar-etanercept-offered-at-47-discount-in-Norway"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1080\/14712598.2018.1430760"},{"key":"CIT0008","unstructured":"European Medicines Agency. Enbrel. Annex I. Summary of product characteristics; [cited 2018 Sep 12]. Available from: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document\/library\/EPAR_-_Product_Information\/human\/000262\/WC500027361.pdf"},{"key":"CIT0009","unstructured":"European Medicines Agency. Benepali. Annex I. Summary of product characteristics; [cited 2018 Sep 12]. Available from: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/human\/004007\/WC500200378.pdf"},{"issue":"44","key":"CIT0010","first-page":"869","volume":"62","author":"Barbour KE","year":"2013","journal-title":"MMWR"},{"issue":"1","key":"CIT0011","first-page":"4","volume":"56","author":"Centers for Disease Control and Prevention","year":"2007","journal-title":"MMWR"},{"key":"CIT0012","unstructured":"Kobelt G, Kasteng F Access to innovative treatments in rheumatoid arthritis in Europe. European Federation of Pharmaceutical Industry Association (EFPIA); 2009 [cited 2018 Oct 2]. Available from: http:\/\/www.comparatorreports.se\/Access%20to%20RA%20Treatments%20October%202009.pdf."},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2016-000259"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12929"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-207588"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2016.1193659"},{"key":"CIT0017","unstructured":"European Medicines Agency. Benepali \u2013 etanercept; [cited 2018 Oct 3]. Available from: https:\/\/www.ema.europa.ej\/documents\/product-information\/benepali-epar-product-information_en.pdf"},{"key":"CIT0018","unstructured":"European Medicines Agency. Guideline on similar biological medicinal products; [cited 2018 Oct 3]. Available from: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2014\/10\/WC500176768.pdf"},{"key":"CIT0019","unstructured":"US Department of Health and Human Services. Food and drug consideration in demonstrating biosimilarity of a therapeutic protein product to a reference product. Guidance for industry; [cited 2018 Oct 3]. Available from: http:\/\/www.fda.gov\/downloads\/drugs\/guidancecomplianceregulatoryinformation\/guidances\/ucm291134.pdf"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kex269"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.16032"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-210101"},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-210127"},{"key":"CIT0024","unstructured":"European Medicines Agency\/CHMP\/819219\/2015Committee for Medicinal Products for Human Use (CHMP) Assessment report. Benepali international non-proprietary name: etanercept. (Procedure No. EMEA\/H\/C\/004007\/0000). [cited 2018 Dec 12]. Available from: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Public_assessment_report\/human\/004007\/WC500200380.pdf"},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2018-224764"},{"key":"CIT0026","first-page":"954","volume":"31","author":"Spinelli FR","year":"2013","journal-title":"Clin Exp Rheumatol"},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2011.04679.x"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2008.06.011"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-201445"},{"key":"CIT0030","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2013-305259"},{"key":"CIT0031","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.22910"},{"key":"CIT0032","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2013.12"},{"key":"CIT0033","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-209665"},{"key":"CIT0034","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-209696"},{"key":"CIT0035","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-210089"},{"key":"CIT0036","unstructured":"European Medicines Agency (EMA). Biosimilars in EU. Information guide for healthcare professionals. London: EMA; 2017 [cited 2018 Dec 12]. Available from: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Leaflet\/2017\/05\/WC500226648.pdf"},{"key":"CIT0037","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-211937"},{"key":"CIT0038","doi-asserted-by":"publisher","DOI":"10.1002\/art.40402"},{"key":"CIT0039","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-212820"},{"key":"CIT0040","first-page":"87","volume":"12","author":"Cantini F","year":"2018","journal-title":"Biologics"},{"key":"CIT0041","doi-asserted-by":"publisher","DOI":"10.1002\/art.40516"},{"issue":"2","key":"CIT0042","first-page":"553","volume":"76","author":"Glintborg B","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"CIT0043","first-page":"961","volume":"77","author":"Alten R","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"CIT0044","doi-asserted-by":"publisher","DOI":"10.1007\/s40744-016-0048-9"},{"key":"CIT0045","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-017-0523-x"}],"container-title":["Expert Opinion on Biological Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14712598.2019.1566456","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,15]],"date-time":"2020-08-15T18:39:12Z","timestamp":1597516752000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14712598.2019.1566456"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,11]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3,4]]}},"alternative-id":["10.1080\/14712598.2019.1566456"],"URL":"https:\/\/doi.org\/10.1080\/14712598.2019.1566456","relation":{},"ISSN":["1471-2598","1744-7682"],"issn-type":[{"value":"1471-2598","type":"print"},{"value":"1744-7682","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,11]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iebt20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iebt20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2018-10-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-01-05","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-01-11","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}